These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22110627)

  • 1. A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.
    Motard J; Rouxel R; Paun A; von Messling V; Bisaillon M; Perreault JP
    PLoS One; 2011; 6(11):e27327. PubMed ID: 22110627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.
    Lainé S; Scarborough RJ; Lévesque D; Didierlaurent L; Soye KJ; Mougel M; Perreault JP; Gatignol A
    RNA Biol; 2011; 8(2):343-53. PubMed ID: 21422817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle.
    Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mimicry of the hepatitis delta virus replication cycle mediated by synthetic circular oligodeoxynucleotides.
    Diegelman AM; Kool ET
    Chem Biol; 1999 Aug; 6(8):569-76. PubMed ID: 10421762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
    Xing Z; Mahadeviah S; Whitton JL
    Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza.
    Zhao H; To KKW; Chu H; Ding Q; Zhao X; Li C; Shuai H; Yuan S; Zhou J; Kok KH; Jiang S; Yuen KY
    Nat Commun; 2018 Jun; 9(1):2358. PubMed ID: 29907765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.
    Ranjan P; Jayashankar L; Deyde V; Zeng H; Davis WG; Pearce MB; Bowzard JB; Hoelscher MA; Jeisy-Scott V; Wiens ME; Gangappa S; Gubareva L; García-Sastre A; Katz JM; Tumpey TM; Fujita T; Sambhara S
    Virol J; 2010 May; 7():102. PubMed ID: 20492658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.
    Wang CX; Lu YQ; Qi P; Chen LH; Han JX
    Virol J; 2010 Mar; 7():61. PubMed ID: 20236514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activity.
    Zhang Z; Burke JM
    J Virol; 2005 Mar; 79(6):3728-36. PubMed ID: 15731266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.
    Cerrone-Szakal AL; Chadalavada DM; Golden BL; Bevilacqua PC
    RNA; 2008 Sep; 14(9):1746-60. PubMed ID: 18658121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
    Davis AM; Ramirez J; Newcomb LL
    Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs.
    Webb CT; Lupták A
    Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.